This website is for educational purposes only and does not constitute investment advice. Always do your own research and assess your own risk tolerance before making investment decisions.

US End-of-Day Verdict 7 Aug 2026, 16:00:00 GMT-4

Berkshire Mirror — End-of-Day Verdict

EOD 2026-08-10

Recommendations

1 to acquire · 3 to dispose

TickerNameCloseActionAction Price Where to act — a buy-limit on a pullback or a buy-stop above resistance, not the current price. Sanity-check vs Close: on a held name, an action price stranded above the close means the queued level was set when the stock was higher — stale, awaiting reprice. Stop The risk-defined exit, set below the entry for a long (~1.2–1.8×ATR). A held long whose Stop sits at/above the Close is already below its stop — a stale box awaiting reprice. 1wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. 4wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. 12wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close. Rationale
BACBank of America Corp63.86ADD — QUEUED @61.9561.9561.1962.64 (+1.1%)64.25 (+3.7%)75.94 (+22.6%)Bank of America is the one name in the book the model still wants to own: it printed STRONG BUY - ADD at conviction 88 on a pullback-to-VWAP setup, closed at a fresh high 17% above its 200-day average, and carries the book's best forward view at +22.6% over twelve weeks. We are not chasing it — the close at is 1.9 ATR past the model's entry, so this goes in as a good-till-cancelled limit that only fills on a pullback to roughly where analysts peg fair value (consensus). Valuation is the one reservation: on a residual-income basis the shares screen rich, which trims a couple of points off conviction, but that gate blocks new positions, not additions to one we already own. OPERATIONAL: 3rd consecutive queue attempt (08-04 @61.32 and 08-05 @61.52 both expired unfilled, 08-06 withdrawn at cv58); entry repriced to tonight's live print per the provenance rule, not carried. PullbackBuy_VWAP|buy is this book's only actionable buy cell and it is NEGATIVE (-1, n=7, hit_4w.00) - L1/US-10 inherited from `us` say prefer this cell, this book's own scorecard says otherwise; the -1 is applied, the L1 preference is not. Quality_Pass=False does NOT gate an ADD to a held name. Trail deliberately HELD at rather than ratcheted to the chandelier - a stop below our own live bid is incoherent; re-raise once the queue fills or expires. Withdraw at the open if the signal family flips off PullbackBuy or conviction drops <65 (US-8). · news
AAPLApple Inc308.26SELL 30%308.26300.00308.74 (+0.2%)n/a314.03 (+1.9%)We are cutting a third of the book's largest holding because the model has now gone three straight sessions unable to read Apple at all, and its twelve-week outlook has collapsed from +3.6% to +1.9% in two sessions - close enough to flat that the forward case has effectively died. Monday supplied the reason: Jefferies downgraded the stock and cut its target from to after supply-chain checks showed Apple has cancelled the 20th-anniversary all-glass iPhone on poor production yields, with rising memory costs and a slow AI rollout on top. Six firms now carry sell-equivalent ratings, the most since 2012, and the shares fell about 2% on the news. The position is essentially flat on cost, so this is risk reduction rather than profit-taking, and we keep the other 70%. OPERATIONAL: pre-committed in the 08-07 entry ('a 3rd NO TRADE with the 12wk turning negative makes AAPL a mandatory dispose'). 12wk is +1.87%, technically positive, but INSIDE the tick-(c) dead-view band (314.03 < 1.02 x 308.26 = 314.43), so the condition is met on the framework's own definition - stated as an assumption. Admitted under CLAUDE.md 9 sustained-NoTrade, NOT ADR-0012 profit-take: Gain_ATR is -0.04 and the PROFIT_ARMED flag is the inverted T12_Progress limb (Systemic finding 1). Tier held at the 30% minimum for that reason and because price sits 9.9% above EMA200. Stop HELD at the event level (2.0xATR chandelier computes 290.88 - lower; trails ratchet up only). Remaining. Ex-div went ex 08-10. · news
MCOMoody's Corp478.14SELL 30%478.14461.27478.32 (+0.0%)n/a480.25 (+0.4%)Moody's has printed two consecutive sessions the model cannot read, and its twelve-week projection has flatlined at +0.4% - there is no forward return left in the position at this price. The business is not the problem: Q2 revenue grew 15%, earnings per share rose 31%, and the buyback was lifted to $3bn. What changed is that management cut 2026 operating-margin guidance, and the shares at ~29.5x earnings are already priced above the peer group, which is exactly what a dead forward view looks like. The stock also sits barely 1% above its 200-day average, so the trend support underneath it is thin. We take a third off and keep the rest. OPERATIONAL: flagged in the 08-07 entry as 'the most likely card of the next two sessions after AAPL' - the second NO TRADE print arrived on schedule. Admitted under 9 sustained-NoTrade (same basis ALLY got on 08-07 at 2 prints); NOT armed (Unreal -2.14%, Gain_ATR -1.02) so ADR-0012 does not apply and the tier stays at 30%. G2 SUPPRESSES the valuation-amplify path (Target_12Week 480.25 > DCF anchor 392.22 = unreliable), so OVERVALUED_VS_RI contributes nothing to the decision - the signal originates alone. Ex-div on 08-14 (3 sessions out) is mechanical (0.22%), NOT an information catalyst, so the catalyst-aware hold does not apply. Stop HELD at (chandelier 457.68 is lower). Remaining. · news
NYTNew York Times Co Cl A64.80SELL 50%64.8058.2763.26 (-2.4%)n/a46.27 (-28.6%)The New York Times has re-armed the sell case we withdrew three sessions ago: it is back to STRONG SELL - REDUCE at conviction 68 and ranks first in the book on sell priority, trading 9.8% below its 200-day average with a twelve-week projection of against today's - a 29% downside view. The business is fine; the market has simply re-rated it. Q2 revenue rose 11%, digital subscription revenue 16% and digital advertising 21%, but the company added 280,000 digital subscribers against the 295,000 expected and guided to persistent cost pressure, and the shares fell 13% on the print and are down about 13% over four weeks. We halve the position rather than exit: at the stock is sitting almost exactly on our intrinsic estimate of and the momentum reading is already oversold, so this is de-risking a broken trend, not calling the business over. OPERATIONAL: the 08-07 card set the re-arm trigger explicitly ('a 2nd SELL-REDUCE print or a close below 56.44') and the 2nd print landed. Only sell candidate tonight clearing the 65 floor on its own merits (68 - 2 = 66). Cell is FailedBreakout_Down_20D|sell (-2, n=34), NOT the book's toxic RallySell_BearTrend|sell (-8) which governed the 08-07 withdrawal - that objection no longer applies. 50% not 88.52% (engine) and not 100%: RSI 34.3 oversold, DCF anchor 63.20 spot, and 30% was already banked at 64.75 on the 08-06 open. Stop RAISED 56.44 -> (2.0xATR chandelier = model Stop_Price). Remaining. · news
DVADaVita Inc183.69NO ACTION183.69174.64180.60 (-1.7%)n/a146.61 (-20.2%)Fourth straight session the model cannot read DaVita, and the twelve-week projection has collapsed from to in six sessions - a 20% downside view on a position already down 22%. Qualifies as a sell on sustained no-read plus a dead forward view. Held back this session because the position was already halved at the 08-07 open and the remaining half was explicitly tied to a break of the 200-day average at, which has not happened (close). OPERATIONAL: ranked 3rd by dollar bleed but displaced by NYT on the un-met EMA200 re-trigger the book wrote down itself - same discipline that vindicated the CVX and OXY deferrals. Mandatory next EOD if EMA200 breaks or a 5th NO TRADE prints. Stop.
ALLYAlly Financial Inc43.79NO ACTION43.7942.6343.58 (-0.5%)n/a41.24 (-5.8%)Third consecutive session with no readable signal and a twelve-week view that has deteriorated again to -5.8%, with the shares only 2.5% above their 200-day average. The sell case is intact and was already approved on 08-07 but never executed. Valuation argues the other way - Ally is one of only two names in the book screening undervalued - which caps this at the minimum 30% trim rather than anything larger. OPERATIONAL: this is the 08-07 card unexecuted, re-priced from 43.72 to tonight's 43.79 per the provenance rule. Ranked 5th by dollar bleed, crowded out by the 3-card cap. UNDERVALUED (MoS +0.05) argues the tier DOWN one step per 9(b) but 30% is already the floor. Mandatory next EOD. Stop.
OXYOccidental Petroleum Corp58.65NO ACTION58.6554.3658.75 (+0.2%)n/a59.89 (+2.1%)A genuine profit-take has fired: the position is up 20% (4.5 ATR above cost) after a 4.9% jump on Monday's energy rally, and a fresh momentum-divergence warning appeared tonight for the first time - strength on deteriorating internals. On our intrinsic work the shares are the most stretched in the book, which pushes the trim from a third to a half. Deferred only because three larger positions took the day's slots. OPERATIONAL: armed on the REAL limb (Gain_ATR 4.54, +19.91%) + tick (a) RSI_DIV, which is NEW tonight - not the same unchanged tick the 08-07 entry declined to re-fire on. G1 does not soften (label is AVOID cv0, not a fresh cv>=80 breakout). MoS_FV -3.07 <= -3 bumps the tier per 9(b); G2 does NOT suppress (DCF anchor 101.91 sits well ABOVE the 59.89 12wk target, so the anchor is reliable). Mandatory next EOD. Trail RAISED 51.96 ->.
VRSNVeriSign Inc293.34NO ACTION293.34276.41296.07 (+0.9%)n/a326.10 (+11.2%)Up 14% and armed for a profit-take, with a fourth consecutive session the model cannot read it. Deferred for a fifth time because the only thing wrong is that the engine has no view - every fundamental line still points up, and the twelve-week projection is the second-best in the book at +11%. OPERATIONAL: armed on the real limb (Gain_ATR 4.36) + tick (d) only. 5th consecutive deferral - the counterfactual series says deferred trims in this book cost a median +4.19% at 4wk (n=33), so this is a measured cost, not a free option (Systemic finding 2). Ex-div on 08-19. Trail RAISED 276.38 ->.
NVRNVR Inc6292.28NO ACTION6292.286010.846245.76 (-0.7%)n/a5734.06 (-8.9%)Five consecutive sessions of STRONG SELL - REDUCE, trading 7.5% below its 200-day average with a -8.9% twelve-week view after a Q2 that missed badly. This is the cleanest sell signal in the book and has been carried unexecuted for eight sessions purely because the position is worth - a line can never outrank a one on dollar bleed. OPERATIONAL: adj 55 after the RallySell_BearTrend|sell -8 haircut, admitted independently by stable-REDUCE + L2 (below EMA200 + negative 12wk). 8th session pending - this is Systemic finding 2's materiality-floor case in its purest form. Stop.
STZConstellation Brands Cl A133.39NO ACTION133.39126.89131.55 (-1.4%)n/a111.24 (-16.6%)Back to STRONG SELL - REDUCE, 8.6% below its 200-day average with a -17% twelve-week view on falling revenue. A dust line carried as a standing close-out. OPERATIONAL: conviction 38, adj 36 - far below the 65 floor - but admitted by L2 (decisive sub-EMA200 + negative 12wk) as a carried close-out, not a fresh card. Stop.
AXPAmerican Express Co338.86HOLD338.86334.75n/an/a339.37 (+0.2%)First STRONG SELL - REDUCE print at conviction 38 on the book's second-largest line, but a single low-conviction flip with the shares still above their 200-day average, a flat twelve-week view and no negative news - Q2 revenue +10%, 2026 guidance raised to 10% growth, dividend up 16%. Not actionable yet; a second print makes it the dominant card. OPERATIONAL: adj 36 after the -2 cell haircut, far below floor. Close sits only above the trail - a breach would trigger L2 on its own.
CBChubb Ltd348.30HOLD348.30341.96n/an/a360.71 (+3.6%)Range-bound HOLD, +3.6% 12wk view, 7.9% above EMA200. Trail (chandelier 335.24 is lower).
COFCapital One Financial Corp218.97HOLD218.97209.77n/an/a255.07 (+16.5%)Recovered NO TRADE -> HOLD cv54, +16.5% 12wk view, +6.75% unrealized. Trail (chandelier 209.49 is lower).
CVXChevron Corp194.91HOLD194.91184.28n/an/a202.47 (+3.9%)The 08-07 profit-take deferral is VINDICATED: +4.5% Monday, conviction, and tick (c) has cleared (12wk 202.47 now above the 1.02x threshold of 198.81). No longer fires. Armed (Gain_ATR 4.84, +15.2%) but not fired -> mandatory trail-raise 179.56 ->. Ex-div on 08-19.
DALDelta Air Lines Inc89.21HOLD89.2186.70n/an/a103.82 (+16.4%)Third NO TRADE but the forward view is the book's third-best at +16.4% and price is 21% above EMA200 - G3 blocks any trim. Trail.
KHCKraft Heinz Co24.93HOLD24.9324.15n/an/a26.30 (+5.5%)HOLD cv64 -> 52, +5.5% 12wk view. Stop held (chandelier 23.09 lower).
KOCoca-Cola Co86.87HOLD86.8783.81n/an/a95.21 (+9.6%)One NO TRADE print, +9.6% 12wk view, 11.5% above EMA200. Trail raised 83.78 ->.
KRKroger Co56.48HOLD56.4854.87n/an/a44.52 (-21.2%)AVOID cv61, -21.2% 12wk view, 12.3% below EMA200 - a dust close-out awaiting a sell label. Stop.
LENLennar Corp Cl A85.60HOLD85.6082.64n/an/a76.49 (-10.6%)dust; -10.6% 12wk, 12.6% below EMA200. Stop.
LEN-BLennar Corp Cl B83.82HOLD83.8281.78n/an/a75.74 (-9.6%)dust; -9.6% 12wk, 10.9% below EMA200. Stop.
LLYVALiberty Live Group Ser A100.42HOLD100.4294.88n/an/a101.45 (+1.0%)Recovered cv0 -> 75; valuation permanently NA (negative book anchor) so fusion is technical-only. Trail raised 93.90 ->.
LLYVKLiberty Live Group Ser C104.46HOLD104.4699.04n/an/a106.83 (+2.3%)Recovered cv0 -> 75; valuation NA. Trail raised 98.01 ->.
MMacy's Inc24.90HOLD24.9024.57n/an/a29.44 (+18.2%)One NO TRADE print, +18.2% 12wk view, +7.1% unrealized. Trail (chandelier 23.02 lower).
NUENucor Corp274.61HOLD274.61259.19n/an/a351.06 (+27.8%)The book's best position (+24.4%, Gain_ATR 6.99) with a +27.8% 12wk view - armed but NO tick fired, so trail-raise not trim. 255.59 -> 256.22 ->.
SIRISirius XM Holdings Inc28.78HOLD28.7828.60n/an/a30.09 (+4.6%)AVOID cv52 - not an actionable sell label. Close is only above the stop, but of the 3.8% two-day fall is the 08-10 ex-dividend, so the real decline is ~2.9%. +4.6% 12wk view. Watch for a breach.

Outcome & track record

Accuracy at the time of this record.

79 Graded decisions Past recommendations old enough to score against what actually happened (target hit / stopped out / closed). This is the evidence base — the bigger the number, the more history behind the calls. Click to inspect every one. See the decisions →
0.006 1-week calibration How much of the eventual 4-week move typically shows up in the first week (0 = almost none, 1 = most of it). Use it to read the 1-week estimates: a low number means prices drift toward the target slowly, so don't over-read a soft week-1.
46 Published records How many dated end-of-day verdicts exist for this book — the length of the public track record you can browse in the Archive below.

This website is for educational purposes only and does not constitute investment advice. Always do your own research and assess your own risk tolerance before making investment decisions.